{"lastClose": 7.920000076293945, "len": 1081, "date": "2023-01-27", "alpha_1": -0.1013175111680662, "beta_1": 1.633656109224532, "drawup_1": 1.5486725887776869, "natr_1": 11.404942023625935, "sup_1": -0.22432659395462004, "res_1": 0.47558918889759344, "bullPattern_1": ["BELTHOLD"], "bearPattern_1": ["HIKKAKE"], "rsi_1": 49.16773298683575, "adx_1": 19.31910845379212, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.013396925715775205, "stratHoldAlpha_1": 250.9906867649305, "stratHoldDrawdown_1": -0.632092538872222, "alpha_3mo": -0.9031254870545664, "beta_3mo": 1.7572289015240647, "drawup_3mo": 0.42170817327753607, "natr_3mo": 11.404942023625935, "sup_3mo": -0.013047155582089322, "res_3mo": 0.08249156323354352, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 73.76623042057281, "adx_3mo": 48.250485583955005, "drawdown_3mo": -0.4781801627958294, "stratHoldSharpe_3mo": -1.36644483938284, "stratHoldAlpha_3mo": 250.1147211180261, "stratHoldDrawdown_3mo": -0.4311628233031225, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 1150075978, "Name": "Allogene Therapeutics Inc.", "Sector": "Health Care", "IPO Year": 2018.0, "alpha%_1": 0.5258177718983447, "beta%_1": 0.8979775187699923, "drawup%_1": 0.9985863103015888, "natr%_1": 0.9994005351765984, "drawdown%_1": 0.07685716968634783, "stratHoldSharpe%_1": 0.3634418212840292, "stratHoldAlpha%_1": 0.3556541895987789, "stratHoldDrawdown%_1": 0.06901416194504603, "alpha%_3mo": 0.04841156196145172, "beta%_3mo": 0.8955981288805237, "drawup%_3mo": 0.8330546874113074, "natr%_3mo": 0.9992374967371326, "drawdown%_3mo": 0.0011049743090300764, "stratHoldSharpe%_3mo": 0.07328099781485656, "stratHoldAlpha%_3mo": 0.02054250423539748, "stratHoldDrawdown%_3mo": 0.0012276810129007003}